Relevant bibliographies by topics / Malaria ; Antimalarial drugs

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Reports

Academic literature on the topic 'Malaria ; Antimalarial drugs'

Author: Grafiati
Published: 4 June 2021
Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Malaria ; Antimalarial drugs.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Malaria ; Antimalarial drugs"

1

Kumar, Lalit, Jyoti Kumar Dinkar, Lalit Mohan, and Harihar Dikshit. "Cost variation analysis of antimalarial drugs available in India." International Journal of Research in Medical Sciences 5, no. 9 (August 26, 2017): 4051. http://dx.doi.org/10.18203/2320-6012.ijrms20173981.

Full text
Abstract:
Background: Malaria has been a problem in India for centuries. There are innumerable brands of antimalarial present in the market. Malaria can be extremely fatal if not treated promptly. Costly drugs can lead to economic burden which results in decreased compliance or even non-compliance. Non-compliance leads to incomplete treatment which tends to increase morbidity. Increase in the patient medication cost was found to be associated with decreased adherence to prescription medication. Hence this study was done to assess the cost variation of malaria therapy.Methods: The maximum and minimum price of each brand of the drug in INR was noted by using CIMS January to April 2017 edition and Drug Today January to March 2017, Vol 2. The cost ratio and the percentage cost variation for individual drug brands was calculated. The cost of 10 tablets was calculated in case of oral drug and the cost of 1 ampoule or vial was noted in case of injectable drug. At last the cost ratio and % cost variation of various brands was compared.Results: The analysis of data reflected a considerable cost variation among antimalarial drugs. Artemether injection showed the highest cost ratio and cost variation (cost ratio = 16.96 and % cost variation = 1596). Overall injectable antimalarials showed considerable cost variation as compared to oral antimalarial agents. Chloroquine which is one of the most used antimalarial showed very low values for cost variation and cost ratio.Conclusions: The analysis showed that there is not much significant price variation among oral antimalarial drugs. The maximum variation shown by oral antimalarial was found to be for fixed dose combination of Artemether and Lumefantrine [cost ratio>2 (2.03) and % price variation >100 (103.7)]. But there was significant price variation among injectable antimalarial. Injectable antimalarials are often the choice of drug when dealing with critically ill malaria patients specially when suffering from complicated malaria. So, such significant price variation creates burden on poor patients economically which leads to non-compliance and hence increased morbidity and mortality due to incomplete treatment.
APA, Harvard, Vancouver, ISO, and other styles
2

Dembele, Laurent, Yaw Aniweh, Nouhoum Diallo, Fanta Sogore, Cheick Papa Oumar Sangare, Aboubecrin Sedhigh Haidara, Aliou Traore, et al. "Plasmodium malariae and Plasmodium falciparum comparative susceptibility to antimalarial drugs in Mali." Journal of Antimicrobial Chemotherapy 76, no. 8 (May 22, 2021): 2079–87. http://dx.doi.org/10.1093/jac/dkab133.

Full text
Abstract:
Abstract Objectives To evaluate Plasmodium malariae susceptibility to current and lead candidate antimalarial drugs. Methods We conducted cross-sectional screening and detection of all Plasmodium species malaria cases, which were nested within a longitudinal prospective study, and an ex vivo assessment of efficacy of a panel of antimalarials against P. malariae and Plasmodium falciparum, both PCR-confirmed mono-infections. Reference compounds tested included chloroquine, lumefantrine, artemether and piperaquine, while candidate antimalarials included the imidazolopiperazine GNF179, a close analogue of KAF156, and the Plasmodium phosphatidylinositol-4-OH kinase (PI4K)-specific inhibitor KDU691. Results We report a high frequency (3%–15%) of P. malariae infections with a significant reduction in ex vivo susceptibility to chloroquine, lumefantrine and artemether, which are the current frontline drugs against P. malariae infections. Unlike these compounds, potent inhibition of P. malariae and P. falciparum was observed with piperaquine exposure. Furthermore, we evaluated advanced lead antimalarial compounds. In this regard, we identified strong inhibition of P. malariae using GNF179, a close analogue of KAF156 imidazolopiperazines, which is a novel class of antimalarial drug currently in clinical Phase IIb testing. Finally, in addition to GNF179, we demonstrated that the Plasmodium PI4K-specific inhibitor KDU691 is highly inhibitory against P. malariae and P. falciparum. Conclusions Our data indicated that chloroquine, lumefantrine and artemether may not be suitable for the treatment of P. malariae infections and the potential of piperaquine, as well as new antimalarials imidazolopiperazines and PI4K-specific inhibitor, for P. malariae cure.
APA, Harvard, Vancouver, ISO, and other styles
3

Bhandari, Prasan R., and Apeksha Bhandary. "Variation of cost among anti-malarial drugs available in Indian market." International Journal of Basic & Clinical Pharmacology 8, no. 11 (October 22, 2019): 2408. http://dx.doi.org/10.18203/2319-2003.ijbcp20194775.

Full text
Abstract:
Background: There are numerous brands of antimalarial existent in the market. Expensive drugs could result in financial drain that causes reduced compliance or even non-compliance. Non-adherence to therapy could consequently cause partial treatment that leads to higher morbidity and in certain cases mortality too. Thus this evaluation was conducted to measure the cost disparity of malaria therapy.Methods: The maximum and minimum price of each brand of the drug in Indian rupee rate was noted by using the latest edition of current index of medical specialities. The cost ratio and the percentage cost variation for individual drug brands were calculated.Results: The analysis of data reflected a considerable cost variation among antimalarial drugs. Chloroquine DS 500 mg showed the highest cost ratio and cost variation (cost ratio=15.3 and % cost variation=1434). Overall injectable antimalarials showed considerable cost variation as compared to oral antimalarial agents.Conclusions: The maximum variation shown by oral antimalarial was found to be for chloroquine DS 500 tablet. But there was significant price variation among injectable antimalarial. Injectable antimalarials are often the choice of drug when dealing with critically ill malaria patients specially when suffering from complicated malaria. So, such significant price variation creates burden on poor patients economically which leads to non-compliance and hence increased morbidity and mortality due to incomplete treatment.
APA, Harvard, Vancouver, ISO, and other styles
4

Choudhary, Amit, Manish Sinha, Arti Devi, Shammy Jindal, and Kamya Goyal. "A Review on Antimalarial 1,2,4-Trioxane Derivatives." Journal of Drug Delivery and Therapeutics 10, no. 4-s (August 15, 2020): 240–53. http://dx.doi.org/10.22270/jddt.v10i4-s.4268.

Full text
Abstract:
Malaria in recent years becomes a major health hitch globally due to the surfacing of multidrug-resistant strains of Plasmodium falciparum parasite. In recent times, artemisinin (ART)-based drugs and combination therapies become the drugs of preference for the treatment and prophylaxis of resistant P. falciparum malaria. Endoperoxide compounds natural, semi-synthetic or synthetic signifying a massive number of antimalarial agents which possess a wide structural miscellany with needed antimalarial effectiveness against resistant P. falciparum malaria. The 1,2,4-trioxane ring system deficient the lactone ring which constitutes the most significant endoperoxide structural scaffold which is believed to be the key pharmacophoric moiety and is principally responsible for the pharmacodynamic potential of endoperoxide-based antimalarials. This becomes the main reason for the research related to endoperoxide particularly 1,2,4-trioxane-, 1,2,4-trioxolane- and 1,2,4,5-tetraoxane-based scaffolds gaining the noteworthy interest in recent years for developing antimalarial drugs against resistant malaria. In this paper, a comprehensive endeavour has been made to review the development of different endoperoxide antimalarial agents and structural diversity of endoperoxide molecules derived from 1,2,4-trioxane- based structural scaffolds. Keywords: Endoperoxide; 1,2,4-trioxane; pharmacophores; artemisinin; antimalarial.
APA, Harvard, Vancouver, ISO, and other styles
5

Tang, Yu-Qing, Qian Ye, He Huang, and Wei-Yi Zheng. "An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance." Current Molecular Medicine 20, no. 8 (December 29, 2020): 583–92. http://dx.doi.org/10.2174/1566524020666200207123253.

Full text
Abstract:
: Malaria is one of the three most deadly infectious diseases in the world and seriously endangers human health and life. To reduce the public health burden of this disease, scientists have focused on the discovery and development of effective antimalarial drugs, from quinine and chloroquine to antifolates and artemisinin and its derivatives, which all play a profound role in the treatment of malaria. However, drugresistant strains of Plasmodium falciparum have emerged due to frequent use of antimalarials and have become increasingly resistant to existing antimalarial drugs, causing disastrous consequences in the world. In particular, artemisinin resistance is of greatest concern which was reported in 2008. Resistance to artenisinins has been a major obstacle for malaria control, and current efforts to curb artemisinin resistance have not been successful. Based on the current situation, it is urgent to develop more effective new antimalarials with distinct targets from conventional antimalarials in the world, which could facilitate to minimize the phenomenon of drug resistance. This review aims to summarize different kinds of antimalarial therapeutic efficacy, mechanisms of action and resistance, and proposes new solutions aiming towards further improvement of malaria elimination.
APA, Harvard, Vancouver, ISO, and other styles
6

Yousif, M. A., and A. A. Adeel. "Antimalarials prescribing patterns in Gezira state: precepts and practices." Eastern Mediterranean Health Journal 6, no. 5-6 (December 15, 2000): 939–47. http://dx.doi.org/10.26719/2000.6.5-6.939.

Full text
Abstract:
A longitudinal pharmacoepidemiological study on prescribing patterns of antimalarials was conducted in Gezira State, Sudan. Different core drug prescribing indicators were identified, measured and correlated. Chloroquine and quinine were the most frequently prescribed antimalaria drugs but in 44.7% of cases, the dosage was inappropriate and did not conform to standard regimens. Due to variable and unmonitored patterns of drug resistance, most medical practitioners in Sudan tend to follow their own protocols to treat severe cases of malaria rather than conforming to standard regimens. We attribute the emergence of a high rate of resistance to malaria chemotherapy to such practices. We recommend interventions to ensure rational prescribing, and call for the formulation of a national antimalarial drugs policy.
APA, Harvard, Vancouver, ISO, and other styles
7

Ujuamala Uloma Ezeani, Penaere Theresa Osahon, and Michael Chukwudi Ezeani. "Pattern of anti-malarial drugs and artemether combination therapy adherence in an institution based medical centre, Nigeria." World Journal of Advanced Research and Reviews 8, no. 3 (December 30, 2020): 162–70. http://dx.doi.org/10.30574/wjarr.2020.8.3.0437.

Full text
Abstract:
The change in policy guidelines for treating uncomplicated malaria became necessary because the therapeutic efficacy of chloroquine and SP had deteriorated. Hence compliance is a necessity to enable effective check on malaria. This work was carried out to evaluate antimalaria drug prescription and to update its usage in line with WHO guideline on Artemeter Combination therapy in a university based medical center. We utilized descriptive, cross-sectional, retrospective study of antimalaria prescriptions purposely carried out among male and female outpatients with mean age of 22.4±2.8 at a University health facility. This comprised all outpatients prescriptions that contained at least one antimalarial drug filed from October 2018 to September 2019. Systematic sampling was used to select the prescriptions. Based on the total number of 1250 prescriptions containing at least one antimalarial drug, a sampling interval of 5 was calculated and simple balloting was used for the first pick. A total number of two hundred and fifty (250) prescriptions containing at least one antimalarial drug were selected for the study. Out of 250 antimalaria prescriptions, usage of ACT class of Artemeter lumefantrine, Artemeter Amodiaquine and Artemeter Piparaqiune were recorded at 45.6%, 10.4% and 9.6% respectively. Triple combination Artemeter lumefantrine and Sulphadoxine-Pyrimethamine was recorded at 20.4% while Sulphadoxine-Pyrimethamine was recorded at 4%. Combination of antimalarial drugs with antibiotics was recorded at 31.2%. This study showed compliance with National Antimalarial Treatment Guideline for the treatment of malaria infection as it regards the use of artemisinin-based combination therapy. The frequency usage of artemeter lumefantrine was proceeding among other ACTs. The frequency in co-prescription of antibiotics with anti-malaria should be guarded to comply with WHO recommendation.
APA, Harvard, Vancouver, ISO, and other styles
8

Orwa, Titus Okello, Rachel Waema Mbogo, and Livingstone Serwadda Luboobi. "Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective." Computational and Mathematical Methods in Medicine 2019 (June 11, 2019): 1–26. http://dx.doi.org/10.1155/2019/9783986.

Full text
Abstract:
The emergence of parasite resistance to antimalarial drugs has contributed significantly to global human mortality and morbidity due to malaria infection. The impacts of multiple-strain malarial parasite infection have further generated a lot of scientific interest. In this paper, we demonstrate, using the epidemiological model, the effects of parasite resistance and competition between the strains on the dynamics and control of Plasmodium falciparum malaria. The analysed model has a trivial equilibrium point which is locally asymptotically stable when the parasite’s effective reproduction number is less than unity. Using contour plots, we observed that the efficacy of antimalarial drugs used, the rate of development of resistance, and the rate of infection by merozoites are the most important parameters in the multiple-strain P. falciparum infection and control model. Although the drug-resistant strain is shown to be less fit, the presence of both strains in the human host has a huge impact on the cost and success of antimalarial treatment. To reduce the emergence of resistant strains, it is vital that only effective antimalarial drugs are administered to patients in hospitals, especially in malaria-endemic regions. Our results emphasize the call for regular and strict surveillance on the use and distribution of antimalarial drugs in health facilities in malaria-endemic countries.
APA, Harvard, Vancouver, ISO, and other styles
9

Afriyie, Daniel Kwame, Seth Kwabena Amponsah, Robert Antwi, Stephen Yayra Nyoagbe, and Kwasi Agyei Bugyei. "Prescribing trend of antimalarial drugs at the Ghana Police Hospital." Journal of Infection in Developing Countries 9, no. 04 (April 15, 2015): 409–15. http://dx.doi.org/10.3855/jidc.5578.

Full text
Abstract:
Introduction: Malaria ranks among the top three leading causes of morbidity and mortality in developing countries. Appropriate use of recommended antimalarial drugs is vital in the effective management of malaria. Methodology: This study sought to assess the prescribing trend of antimalarial drugs at the Ghana Police Hospital. Antimalarial drug prescribing trends from 3,127 patient cards were assessed at the pharmacy unit of the hospital between December 2012 and May 2013 using modified World Health Organization rational drug prescribing indicators. Results: Of the 6,697 drugs assessed from the patient cards, antimalarial drugs prescribed included artemether-lumefantrine, 4,226 (63.1%), artemether injection with artemether-lumefantrine tablets, 1,741 (26%), artesunate injection, 241 (3.6%), artemether injection, 194 (2.9%), and artesunate-amodiaquine tablets, 188 (2.8%). The average number of drugs prescribed per encounter was 2.1. A total of 4,052 (60.5%) drugs were prescribed by their generic names, and 2,645 (39.5%) were prescribed by their brand names. There were 2,250 (33.6%) encounters with injection (33.6%), and 6,001 (89.6%) of the prescribed drugs were from the essential drugs list. Prescriptions conforming to recommended dosage regimen totaled 6,328 (94.5%). Conclusion: The antimalarial prescribing pattern at the hospital was generally satisfactory. However, the use of injectable antimalarials appeared to be high.
APA, Harvard, Vancouver, ISO, and other styles
10

Krishnaswamy, Savitha. "Potent future antimalarials from Indian indigenous plants: a systematic review." International Journal Of Community Medicine And Public Health 6, no. 12 (November 27, 2019): 5364. http://dx.doi.org/10.18203/2394-6040.ijcmph20195500.

Full text
Abstract:
Malaria has a global impact due to development of resistance against the frontline anti-malarial drugs which include artemisinin and its derivatives. According to the ancient Indian system of medicine, the Ayurveda, several Indian indigenous plants have been used for treating various ailments. The use of Indian indigenous plants for treatment of malaria is proving to be quite effective and also offers as a cheaper alternative. The purpose of this review is to obtain knowledge about the different Indian indigenous plants that have antimalarial and antiplasmodial biological activities. Literature suggests that many indigenous Indian plants have shown good antiplasmodial and antimalarial activity with effects like decrease in anaemia, weight loss and pyrexia. Hence the Indian indigenous plants have a vast scope to be used as potent future antimalarials.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Malaria ; Antimalarial drugs"

1

Boakye-Agyeman, Felix. "Quantifying the Quality of Antimalarial Drugs in Ghana." ScholarWorks, 2017. https://scholarworks.waldenu.edu/dissertations/4502.

Full text
Abstract:
Malaria is still an epidemic in many parts of the world-about 220 million people are still infected with malaria worldwide and about 700 thousand people die from this disease per year. Most of the drugs used to treat malaria work well if they are used as required and they contain the right amounts of the active ingredient; however, it is estimated that more than 10% of drugs traded worldwide are counterfeits including 38% to 53% of antimalarial tablets produced in China and India. Due to the lack of data covering the extent of counterfeit antimalarial drugs in Ghana, the purpose of this quantitative study was to determine the percentage of counterfeit antimalarial drugs sold in Ghana by assessing the amounts of the 2 most common antimalarial drugs, artemether (ATMT) and lumefantrine (LMFT) in drugs sold in Ghana retail outlets. These drugs were purchased from retail outlets in Ghana and analyses at the Mayo Clinic Pharmacology core lab (Rochester, MN). The quality of the drugs were characterized by comparing the actual amount of ATMT & LMFT in each tablet to the expected amount. Using explanatory theory along with dose response-response occupancy theory, the researcher addressed quantitative solutions to questions related to the percentage and distribution of counterfeit ATMT and LMFT tablets. The results revealed that overall 20% of the drugs are counterfeit; this is not dependent on the location or kind of outlet but rather depends on whether the tablets were imported or locally manufactured and whether the tablets had a pedigree scratch panel. This study provides a better understanding of how much antimalarial medication is counterfeit in Ghana, which will aid interventions to minimize the adverse effects of counterfeit antimalarial medication in Ghana
APA, Harvard, Vancouver, ISO, and other styles
2

Simpson, Julie Ann. "The role of population pharmacokinetic- pharmacodynamic modelling in antimalarial chemotherapy." Thesis, Open University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ochekpe, N. A. "Some applications of HPLC in the biguanide antimalarial drugs." Thesis, Open University, 1988. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.383660.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dhaliwal, Balvinder. "Crystallographic studies of NAD⁺-dependent L- and D-2-hydroxyacid dehydrogenases." Thesis, University of Bristol, 2001. http://hdl.handle.net/1983/24fdc816-0f14-457e-98d7-b9e9bdc168af.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Slater, Lindsay Anne. "Synthesis and evaluation of polyamines as antimalarial agents." Thesis, University of Glasgow, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.341990.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mukhtar, Amira. "Contemporary approaches to malaria chemotherapy : novel quinoline and peroxide-based antimalarial drugs." Thesis, University of Liverpool, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415571.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wright, Colin W. "Recent developments in research on terrestrial plants used for the treatment of malaria." Royal Society of Chemistry, 2010. http://hdl.handle.net/10454/4541.

Full text
Abstract:
no
New antimalarial drugs are urgently needed to combat emerging multidrug resistant strains of malaria parasites. This Highlight focuses on plant-derived natural products that are of interest as potential leads towards new antimalarial drugs including synthetic analogues of natural compounds, with the exception of artemisinin derivatives, which are not included due to limited space. Since effective antimalarial treatment is often unavailable or unaffordable to many of those who need it, there is increasing interest in the development of locally produced herbal medicines; recent progress in this area will also be reviewed in this Highlight.
APA, Harvard, Vancouver, ISO, and other styles
8

Adagu, Ipemida Sullayman. "Pharmacological and molecular characterisation of Plasmodium falciparum isolates from Zaria, Nigeria." Thesis, London School of Hygiene and Tropical Medicine (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336559.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Khan, Tasmiyah. "Development of a novel, quantitative assay for determining the rate of activity of antimalarial drugs." Thesis, Rhodes University, 2013. http://hdl.handle.net/10962/d1001618.

Full text
Abstract:
Malaria, caused by an intracellular Plasmodium parasite, remains a devastating disease, having claimed approximately 655 000 lives worldwide in 2010. The Medicines for Malaria Venture suggests a "single-dose radical cure" as the ideal malaria treatment since rapid clearance of blood-stage parasites and symptom relief improves patient compliance and limits drug resistance. Thus, novel antimalarials should be rapid-acting and assessing their rate of activity is critical to drug discovery. Traditional evaluation of this rate by morphological assessments is flawed by highly subjective, operator-specific interpretations, mainly due to heterogeneous parasite morphology under routine culture conditions. This study aimed to develop an alternative, quantitative assay. Energy is vital for the growth and maintenance of all living organisms. Commercially available kits allow rapid quantification of the cell's energy currency, ATP. Therefore, quantification of parasite ATP shows potential for diagnosing abnormal parasite metabolism and the kinetics of drug action. In this study, a rapid protocol for detecting ATP in Plasmodium falciparum parasites using a luminescence-based kit was developed and optimised. Furthermore, luciferase-expressing transgenic parasites, in which luciferase activity is detected using a similar kit, were acquired. The utility of both methods for evaluating the rate of drug-induced stress was explored using antimalarials with varying modes of action and, presumably, rates of activity. Results showed that parasite ATP remained unchanged, increased or decreased during drug exposure. Morphological examinations by light microscopy and a Recovery assay, aided interpretation of the drug-induced changes in parasite ATP. These investigations suggested that unchanged parasite ATP levels reflect poor drug action, increased ATP levels indicate a stress response and partially compromised viability, while significantly reduced ATP reflects severely compromised viability. Concerning the Luciferase assay, parasite luciferase activity decreased during drug exposure, even in the presence of proteasome inhibitors. Changes in parasite ATP and luciferase activity occurred at rates which suggested that chloroquine is slow-acting, mefloquine has a moderate rate of activity and artemisinin is rapid-acting. These findings are compatible with the expected rates of activity of these established antimalarials. Hence, measurement of parasite ATP and/or luciferase activity may support assessments of parasite health and the kinetics of antimalarial action during drug discovery
APA, Harvard, Vancouver, ISO, and other styles
10

Kloprogge, Frank Lodewijk. "Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:79ce1a37-3ba2-45e4-9f80-0692a66837f1.

Full text
Abstract:
Malaria is the most important parasitic disease in man and it kills approximately 2,000 people each day. Pregnant women are especially vulnerable to malaria with increased incidence and mortality rates. There are indications that pregnancy alters the pharmacokinetic properties of many antimalarial drugs. This is worrisome as lower drug exposures might result in lowered efficacy and lower drug exposures can also accelerate the development and spread of resistant parasites. The aim of this research was to study the pharmacokinetics and pharmacodynamics of the most commonly used drugs for the treatment of uncomplicated Plasmodium falciparum malaria during the second and third trimester of pregnancy using a pharmacometric approach. This thesis presents a number of important findings that increase the current knowledge of antimalarial drug pharmacology and that may have an impact in terms of drug efficacy and resistance. (1) Lower lumefantrine plasma concentrations at day 7 were evident in pregnant women compared to that in non-pregnant patients. Subsequent in-silico simulations with the final pharmacokinetic-pharmacodynamic lumefantrine/desbutyl-lumefantrine model showed a decreased treatment failure rate after a proposed extended artemether-lumefantrine treatment. (2) Dihydroartemisinin exposure (after intravenous and oral administration of artesunate) was lower during pregnancy compared to that in women 3 months post-partum (same women without malaria). Consecutive in-silico simulations with the final model showed that the underexposure of dihydroartemisinin during pregnancy could be compensated by a 25% dose increase. (3) Artemether/dihydroartemisinin exposure in pregnant women was also lower compared to literature values in non-pregnant patients. This further supports the urgent need for a study in pregnant women with a non-pregnant control group. (4) Quinine pharmacokinetics was not affected by pregnancy trimester within the study population and a study with a non-pregnant control group is needed to evaluate the absolute effects of pregnancy. (5) Finally, a data-dependent power calculation methodology using the log likelihood ratio test was successfully used for sample size calculations of mixed pharmacokinetic study designs (i.e. sparsely and densely sampled patients). Such sample size calculations can contribute to a better design of future pharmacokinetic studies. In conclusion, this thesis showed lower exposures for drugs used to treat uncomplicated Plasmodium falciparum malaria during the second and third trimester of pregnancy. More pharmacokinetic studies in pregnant women with a non-pregnant control group are urgently needed to confirm the current findings and to enable an evidence-based dose optimisation. The data-dependent power calculation methodology using the log likelihood ratio test can contribute to an effective design of these future pharmacokinetic studies.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Malaria ; Antimalarial drugs"

1

Csizmadia, Emanuel. Antimalarial drugs: Costs, safety and efficacy. New York: Nova Biomedical Books, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Peters, Wallace. Chemotherapy and drug resistance in malaria. 2nd ed. London: Academic Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Staines, Henry M. Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use. Basel: Springer Basel, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

World Health Organization (WHO). Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Honigsbaum, Mark. The fever trail: In search of the cure for malaria. New York: Farrar, Straus and Giroux, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

The fever trail: The hunt for the cure for malaria. London: Macmillan, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Microbiology, American Society for, ed. Magic bullets to conquer malaria: From quinine to qinghaosu. Washington, DC: ASM Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Arrow, Kenneth Joseph, Hellen Gelband, and Claire Panosian. Saving lives, buying time: Economics of malaria drugs in an age of resistance. Edited by Institute of Medicine (U.S.). Committee on the Economics of Antimalarial Drugs and NetLibrary Inc. Washington, D.C: National Academies Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Peters, W., R. Baurain, P. E. Carson, R. Ferone, C. D. Fitch, W. Hofheinz, A. T. Hudson, et al. Antimalarial Drug II: Current Antimalarial and New Drug Developments. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Emanuel, Csizmadia, and Kalnoky Istvan, eds. Antimalarial drugs: Costs, safety, and efficacy. Hauppauge, NY: Nova Science, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Malaria ; Antimalarial drugs"

1

Clain, Jerome, Abderaouf Hamza, and Frédéric Ariey. "Antimalarial Drugs for Malaria Elimination." In Methods in Molecular Biology, 151–62. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9550-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Na-Bangchang, Kesara, and Juntra Karbwang. "Pharmacology of Antimalarial Drugs, Current Anti-malarials." In Encyclopedia of Malaria, 1–82. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4614-8757-9_149-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sevene, Esperança, and Xavier Carné. "Control of Malaria During Pregnancy: Safety of Antimalarial Drugs." In Encyclopedia of Malaria, 1–8. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-8757-9_69-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mehlotra, Rajeev K., and Peter A. Zimmerman. "Resistance to Antimalarial Drugs: Parasite and Host Genetic Factors." In Malaria: Genetic and Evolutionary Aspects, 81–124. Boston, MA: Springer US, 2006. http://dx.doi.org/10.1007/0-387-28295-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Barnes, Karen I. "Antimalarial Drugs and the Control and Elimination of Malaria." In Treatment and Prevention of Malaria, 1–17. Basel: Springer Basel, 2011. http://dx.doi.org/10.1007/978-3-0346-0480-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shah, Naman K., and Neena Valecha. "Antimalarial drug resistance." In Advances in Malaria Research, 383–407. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2016. http://dx.doi.org/10.1002/9781118493816.ch14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cheah, Phaik Yeong, Michael Parker, and Nicholas P. J. Day. "Ethics and Antimalarial Drug Resistance." In Ethics and Drug Resistance: Collective Responsibility for Global Public Health, 55–73. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-27874-8_4.

Full text
Abstract:
Abstract There has been impressive progress in malaria control and treatment over the past two decades. One of the most important factors in the decline of malaria-related mortality has been the development and deployment of highly effective treatment in the form of artemisinin-based combination therapies (ACTs). However, recent reports suggest that these gains stand the risk of being reversed due to the emergence of ACT resistance in the Greater Mekong Subregion and the threat of this resistance spreading to Africa, where the majority of the world’s malaria cases occur, with catastrophic consequences. This chapter provides an overview of strategies proposed by malaria experts to tackle artemisinin-resistant malaria, and some of the most important practical ethical issues presented by each of these interventions. The proposed strategies include mass antimalarial drug administrations in selected populations, and mandatory screening of possibly infected individuals prior to entering an area free of artemisinin-resistant malaria. We discuss ethical issues such as tensions between the wishes of individuals versus the broader goal of malaria elimination, and the risks of harm to interventional populations, and conclude by proposing a set of recommendations.
APA, Harvard, Vancouver, ISO, and other styles
8

Uhlemann, Anne-Catrin, Yongyuth Yuthavong, and David A. Fidock. "Mechanisms of Antimalarial Drug Action and Resistance." In Molecular Approaches to Malaria, 427–61. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555817558.ch23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kundu, Ritabrata, and Jaydeep Choudhury. "Antimalarial Drugs." In Clinic Consult: Pediatrics (Malaria), 52. Jaypee Brothers Medical Publishers (P) Ltd., 2016. http://dx.doi.org/10.5005/jp/books/12879_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Teng, Woon-Chien, Ho Han Kiat, Rossarin Suwanarusk, and Hwee-Ling Koh. "Current Antimalarial Drugs." In Medicinal Plants and Malaria, 9–48. CRC Press, 2016. http://dx.doi.org/10.1201/b19026-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Malaria ; Antimalarial drugs"

1

Liebman, Katherine. New 4-Aminoquinoline Compounds to Reverse Drug Resistance in P. falciparum Malaria, and a Survey of Early European Antimalarial Treatments. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.2112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Malaria ; Antimalarial drugs' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography